Results 51 to 60 of about 15,817 (237)

Subcutaneous implantable cardioverter‐defibrillator noise following left ventricular assist device implantation

Journal of Arrhythmia, 2023
Background The incidence and impact of noise in a subcutaneous implantable cardioverter defibrillator (S‐ICD) after left ventricular assist device (LVAD) implantation is not well established.
Banveet Kaur Khetarpal, Awad Javaid, Justin Z. Lee, Fred Kusumoto, Siva K. Mulpuru, Dan Sorajja, Yong‐Mei Cha, Komandoor Srivathsan   +7 more
doaj   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger, Elric Zweck, Constanze Moos, Patrick Horn, Fabian Voß, Heinz‐Peter Schultheiss, Jacob Eifer Møller, Udo Boeken, Hug Aubin, Artur Lichtenberg, Malte Kelm, Michael Roden, Amin Polzin, Ralf Westenfeld, Julia Szendroedi, Daniel Scheiber   +15 more
wiley   +1 more source

Replacement of failing HeartMate XVE LVAD with HeartMate II LVAD in patients awaiting heart transplantation

, 2007
9 patients with a failing Heartmate XVE pulsatile LVAD and indication for LVAD replacement were switched to Heartmate II non-pulsatile LVAD. Anticoagulation was achieved with coumadin and antiaggregation with aspirin.
Reverdin, S, Kar, B, Ghodsizad, A, Gregoric, I, Frazier, O H   +4 more
core   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Pexy of intraperitoneal LVAD driveline to relieve small bowel obstruction

, 2020
Background Left ventricular assist device (LVAD) implantation is a lifesaving intervention in advanced heart failure. However, LVAD is not without complication.
Urrechaga, Eva M, Lieberman, Howard M, Cresse, Stephen M, Banerjee, Monisha N, Cahill, Anthony, Cioci, Alessia C   +5 more
core   +1 more source

Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review

Frontiers in Cardiovascular Medicine, 2021
Aims: Major adverse event (MAE) rates during left ventricular assist device (LVAD) therapy in advanced heart failure (HF) patients are high, and impair quality of life and survival.
Eva Janssen, J. Wouter Jukema, Saskia L. M. A. Beeres, Martin J. Schalij, Laurens F. Tops   +4 more
doaj   +1 more source

Impact of Gentamicin‐Impregnated Collagen Sponge on the Incidence of Access Related Infections After Full‐Support Microaxial Flow Pump Therapy

Artificial Organs, EarlyView.
Local application of gentamicin for wound closure after full‐support microaxial flow pump therapy. ABSTRACT Background Surgically implanted microaxial flow pumps (mAFP) are increasingly used for cardiogenic shock treatment. Standard mAFP explantation is performed bedside with a shortening of the vascular prosthesis, which may represent a potential ...
Gaik Nersesian, Maximilian Rauch, Daniel Lewin, Leonard Pitts, Julius Kaemmel, Anna Stegmann, Julia Stein, Yuriy Hrytsyna, Felix Schoenrath, Volkmar Falk, Evgenij Potapov, Pia Lanmueller   +11 more
wiley   +1 more source

LVAD pannus complicating destination therapy

, 2017
Despite advances in technology, ventricular assist devices still experience a number of complications limiting their long-term use. We present a 73-year-old woman implanted with a left ventricular assist device (LVAD) five years prior due to end-stage ...
Margaret Robin B. Cases, Davide Salina, Elizabeth Swiggum, Maya Ignaszewski, Anson Cheung, Michael A. Seidman, Andrew P. Ignaszewski   +6 more
core   +1 more source

Analyzed LVAD waveform parameters.

, 2020
LVAD pump flow features analyzed to characterize patients’ response to exercise. For description of symbols please refer to the text.
Libera Fresiello (4268050), Heinrich Schima (8043344), Christiane Marko (8595759), Christoph Gross (8595750), Dominik Wiedemann (388586), Francesco Moscato (8413617), Martin Maw (8595762), Thomas Schlöglhofer (8595753), Kamen Dimitrov (8595756), Daniel Zimpfer (7900883), Bart Meyns (4268044)   +10 more
core   +1 more source

Percutaneous Intervention in External Outflow Graft Obstruction of Magnetically Levitated Left Ventricular Assist Device: Long‐Term Follow‐Up and Quality of Life

Artificial Organs, EarlyView.
eOGO is an uncommon adverse event in patients on long‐term LVAD support. Thirty‐one eOGO patients were identified in a single‐centre HM3 implantation program. Twenty patients underwent percutaneous stenting. This treatment resulted in immediate LVAD flow improvement and yielded satisfactory quality‐of‐life results, with 62.5% patients assigned a fair ...
Anna Huang, Julia Stein, Vanessa I. T. Zwaans, Carla L. Schuering, Gaik Nersesian, Christoph Hoermandinger, Markus Müller, Johanna Mulzer, Stephan Dreysse, Philipp Stawowy, Christoph T. Starck, Joerg Kempfert, Evgenij V. Potapov, Volkmar Falk, Leonhard Wert   +14 more
wiley   +1 more source